{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:59:42Z","timestamp":1794373182679,"version":"4.9.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1111\/j.1574-695x.2006.00110.x","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T13:08:16Z","timestamp":1149599296000},"page":"254-261","source":"Crossref","is-referenced-by-count":33,"title":["Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of<i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.1093","volume":"47","author":[{"given":"Raja'a","family":"Al-Attiyah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada M.","family":"Madi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-salaam M.","family":"El-Shamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald G.","family":"Wiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu S.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB1","doi-asserted-by":"crossref","unstructured":"Agger EM , Weldingh K , Olsen AW , Rosenkrands I & Andersen P (2002) Specific acquired resistance in mice immunized with killed mycobacteria. Scand J Immunol 56: 443\u00e2\u0080\u0093447.","DOI":"10.1046\/j.1365-3083.2002.01152.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB2","doi-asserted-by":"crossref","unstructured":"Al-Attiyah R , Shaban FA , Wiker HG , Oftung F & Mustafa AS (2003) Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 71: 1953\u00e2\u0080\u00931960.","DOI":"10.1128\/IAI.71.4.1953-1960.2003"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB3","doi-asserted-by":"crossref","unstructured":"Amoudy HA , Al-Asmer ABH , Abul AT & Mustafa AS (1997) Evaluation of complex and defined antigens of Mycobacterium tuberculosis in an IgG-specific ELISA for the diagnosis of tuberculosis. Med Princ Pract 6: 103\u00e2\u0080\u0093109.","DOI":"10.1159\/000157434"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB4","doi-asserted-by":"crossref","unstructured":"Andersen P , Andersen AB , Sorensen AL & Nagai S (1995) Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 154: 3359\u00e2\u0080\u00933372.","DOI":"10.4049\/jimmunol.154.7.3359"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB5","unstructured":"Andersen P & Doherty TM (2005) TB subunit vaccines \u00e2\u0088\u0092 putting the pieces together. Microbes infect 7: 911\u00e2\u0080\u0093921."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB6","unstructured":"Bai X , Wilson SE , Chmura K , Feldman NE & Chan ED (2004) Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb) 84: 375\u00e2\u0080\u0093385."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB7","doi-asserted-by":"crossref","unstructured":"Bal AM , Lakhashe SK , Thakar MR , Tripathy SP & Paranjape RS (2005) Dysregulation of proinflammatory and regulatory cytokines in HIV infected persons with active tuberculosis. Cytokine 30: 275\u00e2\u0080\u0093281.","DOI":"10.1016\/j.cyto.2005.01.015"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB8","doi-asserted-by":"crossref","unstructured":"Barnes PF , Lu S , Abrams JS , Wang E , Yamamura M & Modlin RL (1993) Cytokine production at the site of disease in human tuberculosis. Infect Immun 61: 3482\u00e2\u0080\u00933489.","DOI":"10.1128\/IAI.61.8.3482-3489.1993"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB9","doi-asserted-by":"crossref","unstructured":"Brandt L , Oettinger T , Holm A , Andersen A & Andersen P (1996) Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 157: 3527\u00e2\u0080\u00933533.","DOI":"10.4049\/jimmunol.157.8.3527"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB42","doi-asserted-by":"crossref","unstructured":"Cardoso FL , Antas PR , Milagres AS , et al. (2002) T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients. Infect Immun 70: 6707\u00e2\u0080\u00936714.","DOI":"10.1128\/IAI.70.12.6707-6714.2002"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB10","doi-asserted-by":"crossref","unstructured":"Demissie A , Abebe M , Aseffa A , Rook G , Fletcher H , Zumla A , Weldingh K , Brock I , Andersen P , Doherty TM & VACSEL Study Group (2004) Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172: 6938\u00e2\u0080\u00936943.","DOI":"10.4049\/jimmunol.172.11.6938"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB11","unstructured":"Derrick SC , Yang AL & Morris SL (2004) A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacteriumtuberculosis and boosts BCG-induced protective immunity. Vaccine 23: 780\u00e2\u0080\u0093788."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB12","unstructured":"Dye C , Watt CJ , Bleed DM , Hosseini SM & Raviglione MC (2005) Evaluation of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293: 2767\u00e2\u0080\u00932775."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB13","unstructured":"Espinal MA , Laszlo A , Simonsen L , et al. (2001) Global trends in resistance to anti-tuberculosis drugs. World Health Organization \u00e2\u0088\u0092 International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New Engl J Med 344: 1294\u00e2\u0080\u00931303."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB14","doi-asserted-by":"crossref","unstructured":"Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339\u00e2\u0080\u00931345.","DOI":"10.1016\/S0140-6736(95)92348-9"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB15","doi-asserted-by":"crossref","unstructured":"Flynn J (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis 4: 93\u00e2\u0080\u0093101.","DOI":"10.1016\/j.tube.2003.08.010"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB16","unstructured":"Gong J , Zhang M , Modlin RL , Linsley PS , Iyer D , Lin Y & Barnes FY (1996) Interleukin-10 downregulates Mycobacterium tuberculosis induced Th1 responses and CLTA-4 expression. Infect Immun 9: 913\u00e2\u0080\u0093918."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB17","doi-asserted-by":"crossref","unstructured":"Harboe M , Malin AS , Dockrell HS , Wiker HG , Ulvund G , Holm A , Jorgensen MC & Andersen P (1998) B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 66: 717\u00e2\u0080\u0093723.","DOI":"10.1128\/IAI.66.2.717-723.1998"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB18","doi-asserted-by":"crossref","unstructured":"Lai CKW , Ho S , Chan CHS , Chan J , Choy D , Leung R & Lai K (1997) Cytokine gene expression profile of circulating CD4+T cells in active pulmonary tuberculosis. Chest 111: 606\u00e2\u0080\u0093611.","DOI":"10.1378\/chest.111.3.606"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB19","unstructured":"Lalvani A , Nagvenkar P , Udwadia Z , Pathan AA , Wilkinson KA , Shastri JS , Ewer K , Hill AV , Mehta A & Rodrigues C (2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacteriumtuberculosis infection in healthy urban Indians. J Infect Dis 83: 469\u00e2\u0080\u0093477."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB20","doi-asserted-by":"crossref","unstructured":"Langermans JA , Doherty TM , Vervenne RAW , et al. (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23: 2740\u00e2\u0080\u00932750.","DOI":"10.1016\/j.vaccine.2004.11.051"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB21","doi-asserted-by":"crossref","unstructured":"Lin Y , Zhang M , Hofman FM , Gong J & Barnes PF (1996) Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 64: 1351\u00e2\u0080\u00931356.","DOI":"10.1128\/IAI.64.4.1351-1356.1996"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB22","doi-asserted-by":"crossref","unstructured":"Mohan VP , Scanga CA , Yu K , Scott HM , Tanaka KE , Tsang E , Tsai MM , Flynn JL & Chan J (2001) Effects of Tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69: 1847\u00e2\u0080\u00931855.","DOI":"10.1128\/IAI.69.3.1847-1855.2001"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB23","unstructured":"Morosini M , Meloni F , Uccelli M , Marone Bianco A , Solari N & Fietta AM (2005) Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis. Int J Tuberc Lung Dis 9: 753\u00e2\u0080\u0093759."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB24","doi-asserted-by":"crossref","unstructured":"Moura EP , Toledo VPCP , Oliveira MHP , Spindola-de-Mirnada S , Andrade HM & Guimaraes TMPD (2004) Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin. Mem Inst Oswaldo Cruz 99: 283\u00e2\u0080\u0093287.","DOI":"10.1590\/S0074-02762004000300008"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB25","first-page":"47","volume-title":"Focus on Tuberculosis Research","author":"Mustafa","year":"2005"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB26","unstructured":"Mustafa AS & Al-Attiyah R (2003) Tuberculosis: looking beyond BCG vaccines. J Postgrad Med 49: 134\u00e2\u0080\u0093140."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB27","doi-asserted-by":"crossref","unstructured":"Mustafa AS , Amoudy HA , Wiker HG , Abal AT , Ravn P , Oftung F & Andersen P (1998) Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 48: 535\u00e2\u0080\u0093543.","DOI":"10.1046\/j.1365-3083.1998.00419.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB28","doi-asserted-by":"crossref","unstructured":"North RJ (1998) Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113: 55\u00e2\u0080\u009358.","DOI":"10.1046\/j.1365-2249.1998.00636.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB29","doi-asserted-by":"crossref","unstructured":"Poveda F , Camacho J , Arnalich F , Codoceo R , del Arco A & Martinez-Hernandez P (1999) Circulating cytokine concentrations in tuberculosis and other chronic bacterial infections. Infection 27: 272\u00e2\u0080\u0093274.","DOI":"10.1007\/s150100050028"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB30","unstructured":"Ravn P , Demissie A , Eguale T , et al. (1999) Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 179: 637\u00e2\u0080\u0093645."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB31","doi-asserted-by":"crossref","unstructured":"Roche PW , Feng CG & Britton WJ (1996a) Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand J Immunol 43: 662\u00e2\u0080\u0093670.","DOI":"10.1046\/j.1365-3083.1996.d01-260.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB32","doi-asserted-by":"crossref","unstructured":"Roche PW , Winter N , Triccas JA , Feng CG & Britton WJ (1996b) Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycobacterium smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol 103: 226\u00e2\u0080\u0093232.","DOI":"10.1046\/j.1365-2249.1996.d01-613.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB33","unstructured":"Salina T & Morozova T (2004) Production of gamma-interferon by blood mononuclear cells in patients with various types of a tuberculous process. Probl Tuberk Bolezn Legk 10: 19\u00e2\u0080\u009321."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB34","unstructured":"Sieling PA , Abrams JS , Yamamura M , Salgame P , Bloom BR , Rea TH & Modlin RL (1993) Immunosuppression roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 150: 5501\u00e2\u0080\u00935510."},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB35","doi-asserted-by":"crossref","unstructured":"Sorensen AL , Nagai S , Houen G , Andersen P & Andersen AB (1995) Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63: 1710\u00e2\u0080\u00931717.","DOI":"10.1128\/IAI.63.5.1710-1717.1995"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB36","doi-asserted-by":"crossref","unstructured":"Taha RA , Kotsimbos TC , Song YL , Menzies D & Hamid Q (1997) IFN-\u00ce\u00b3 and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 155: 1135\u00e2\u0080\u00931139.","DOI":"10.1164\/ajrccm.155.3.9116999"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB37","doi-asserted-by":"crossref","unstructured":"Turner J , Gonzalez-Juarrero M , Ellis DL , Basaraba RJ , Kipnis A , Orme IM & Cooper AM (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL\/6 mice. J Immunol 169: 6343\u00e2\u0080\u00936351.","DOI":"10.4049\/jimmunol.169.11.6343"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB38","doi-asserted-by":"crossref","unstructured":"Ulrichs T , Anding P , Porcelli S , Kaufmann SHE & Munk ME (2000) Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun 68: 6073\u00e2\u0080\u00936076.","DOI":"10.1128\/IAI.68.10.6073-6076.2000"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB39","doi-asserted-by":"crossref","unstructured":"Vekemans J , Lienhardt C , Sillah JS , Wheeler JG , Lahai GP , Doherty MT , Corrah T , Andersen P , McAdam KP & Marchant A (2001) Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 69: 6554\u00e2\u0080\u00936557.","DOI":"10.1128\/IAI.69.10.6554-6557.2001"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB40","doi-asserted-by":"crossref","unstructured":"Verbon A , Juffermans N , Van Deventer SJH , Speelman P , Van Deutekom H & Van Der Poll T (1999) Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 115: 110\u00e2\u0080\u0093113.","DOI":"10.1046\/j.1365-2249.1999.00783.x"},{"key":"10.1111\/j.1574-695X.2006.00110.x-BIB41","doi-asserted-by":"crossref","unstructured":"Zhang M , Lin Y , Iyer D , Gong J , Abrams J & Barnes P (1995) T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63: 3231\u00e2\u0080\u00933234.","DOI":"10.1128\/IAI.63.8.3231-3234.1995"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/47\/2\/254\/19169092\/47-2-254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T17:50:56Z","timestamp":1707069056000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2006.00110.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2006.00110.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}